Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Molecular Cell
|
September 16, 2014
The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype
Minggang Fang, Jianhong Ou, Lloyd Hutchinson, et al.
European Journal of Haematology
|
May 9, 2008
Clinicopathological features of extramedullary recurrence/relapse of multiple myeloma
Jan Cerny, Oluwole Fadare, Lloyd Hutchinson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 21, 2016
Common BRAF(V600E)-directed pathway mediates widespread epigenetic silencing in colorectal cancer and melanoma
Minggang Fang, Lloyd Hutchinson, April Deng, et al.
JCI Insight
|
September 8, 2022
Pathological MAPK activation-mediated lymphatic basement membrane disruption causes lymphangiectasia that is treatable with ravoxertinib
Harish P Janardhan, Karen Dresser, Lloyd Hutchinson, et al.
Journal of the American Society of Cytopathology
|
May 5, 2019
Intranuclear cytoplasmic inclusions are a specific feature of intraductal papillary mucinous neoplasms that distinguish contaminating gastric epithelium
Paul J Lee, Christopher L Owens, Lloyd Hutchinson, et al.
Cancer Genetics and Cytogenetics
|
May 14, 2008
Trisomy 8 in B-cell chronic lymphocytic leukemia
Olga Pozdnyakova, Dariusz Stachurski, Lloyd Hutchinson, et al.
Journal of the American Society of Cytopathology
|
November 13, 2019
Sequential molecular and cytologic analyses provides a complementary approach to the diagnosis of pancreatic cystic lesions: a decade of clinical practice
Ali Sakhdari, Parnian Ahmadi Moghaddam, Martina Pejchal, et al.
Rare Tumors
|
December 23, 2020
Molecular analysis of a rare case of low-grade primary peritoneal serous carcinoma in a male
Vladislav V Makarenko, Dina Kandil, Ediz F Cosar, et al.
The Journal of Experimental Medicine
|
May 15, 2020
KRAS or BRAF mutations cause hepatic vascular cavernomas treatable with MAP2K-MAPK1 inhibition
Harish Palleti Janardhan, Xiuling Meng, Karen Dresser, et al.
Virchows Archiv : an International Journal of Pathology
|
June 5, 2016
Somatic mutations in histiocytic sarcoma identified by next generation sequencing
Qingqing Liu, Keith Tomaszewicz, Lloyd Hutchinson, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Molecular Cell
|
September 16, 2014
The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype
Minggang Fang, Jianhong Ou, Lloyd Hutchinson, et al.
European Journal of Haematology
|
May 9, 2008
Clinicopathological features of extramedullary recurrence/relapse of multiple myeloma
Jan Cerny, Oluwole Fadare, Lloyd Hutchinson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 21, 2016
Common BRAF(V600E)-directed pathway mediates widespread epigenetic silencing in colorectal cancer and melanoma
Minggang Fang, Lloyd Hutchinson, April Deng, et al.
JCI Insight
|
September 8, 2022
Pathological MAPK activation-mediated lymphatic basement membrane disruption causes lymphangiectasia that is treatable with ravoxertinib
Harish P Janardhan, Karen Dresser, Lloyd Hutchinson, et al.
Journal of the American Society of Cytopathology
|
May 5, 2019
Intranuclear cytoplasmic inclusions are a specific feature of intraductal papillary mucinous neoplasms that distinguish contaminating gastric epithelium
Paul J Lee, Christopher L Owens, Lloyd Hutchinson, et al.
Cancer Genetics and Cytogenetics
|
May 14, 2008
Trisomy 8 in B-cell chronic lymphocytic leukemia
Olga Pozdnyakova, Dariusz Stachurski, Lloyd Hutchinson, et al.
Journal of the American Society of Cytopathology
|
November 13, 2019
Sequential molecular and cytologic analyses provides a complementary approach to the diagnosis of pancreatic cystic lesions: a decade of clinical practice
Ali Sakhdari, Parnian Ahmadi Moghaddam, Martina Pejchal, et al.
Rare Tumors
|
December 23, 2020
Molecular analysis of a rare case of low-grade primary peritoneal serous carcinoma in a male
Vladislav V Makarenko, Dina Kandil, Ediz F Cosar, et al.
The Journal of Experimental Medicine
|
May 15, 2020
KRAS or BRAF mutations cause hepatic vascular cavernomas treatable with MAP2K-MAPK1 inhibition
Harish Palleti Janardhan, Xiuling Meng, Karen Dresser, et al.
Virchows Archiv : an International Journal of Pathology
|
June 5, 2016
Somatic mutations in histiocytic sarcoma identified by next generation sequencing
Qingqing Liu, Keith Tomaszewicz, Lloyd Hutchinson, et al.
Page
of 5